Christian G. Hartinger

Challenges and Opportunities in the Development of Organometallic Anticancer Drugs

Christian G. Hartinger, Nils Metzler‐Nolte, Paul J. Dyson · Organometallics · 2012 · 550 citations · Full text

Organometallic Anticancer Compounds, Organic Chemistry, Chemistry +17

The development of RAPTA compounds for the treatment of tumors

Benjamin S. Murray, Maria V. Babak, Christian G. Hartinger et al. · Coordination Chemistry Reviews · 2015 · 449 citations · Full text

Tumor Biology, Medicinal Chemistry, Medicine +7

Emerging Protein Targets for Anticancer Metallodrugs: Inhibition of Thioredoxin Reductase and Cathepsin B by Antitumor Ruthenium(II)−Arene Compounds

Angela Casini, Chiara Gabbiani, Francesca Sorrentino et al. · Journal of Medicinal Chemistry · 2008 · 265 citations · Full text

Medicinal Chemistry, Protein Targets, Representative Rapta +15

Gold(III) compounds as anticancer agents: Relevance of gold–protein interactions for their mechanism of action

Angela Casini, Christian G. Hartinger, Chiara Gabbiani et al. · Journal of Inorganic Biochemistry · 2007 · 263 citations · Full text

Medicinal Chemistry, Drug Targeting, Chemoprevention Strategy +10

Opening the lid on piano-stool complexes: An account of ruthenium(II)–arene complexes with medicinal applications

Alexey A. Nazarov, Christian G. Hartinger, Paul J. Dyson · Journal of Organometallic Chemistry · 2013 · 259 citations · Full text

Inorganic Chemistry, Medicinal Chemistry, Biochemistry +8